Cargando…
Molecular pathogenesis of long QT syndrome type 2
The molecular mechanisms underlying congenital long QT syndrome (LQTS) are now beginning to be understood. New insights into the etiology and therapeutic strategies are emerging from heterologous expression studies of LQTS-linked mutant proteins, as well as inducible pluripotent stem cell derived ca...
Autores principales: | Smith, Jennifer L., Anderson, Corey L., Burgess, Don E., Elayi, Claude S., January, Craig T., Delisle, Brian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063260/ https://www.ncbi.nlm.nih.gov/pubmed/27761161 http://dx.doi.org/10.1016/j.joa.2015.11.009 |
Ejemplares similares
-
Visualizing Mutation-Specific Differences in the Trafficking-Deficient Phenotype of Kv11.1 Proteins Linked to Long QT Syndrome Type 2
por: Hall, Allison R., et al.
Publicado: (2018) -
Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020) -
Large-scale Mutational Analysis of Kv11.1 Reveals Molecular Insights into Type 2 Long QT Syndrome
por: Anderson, Corey L., et al.
Publicado: (2014) -
Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes
por: Kekenes-Huskey, Peter M., et al.
Publicado: (2022) -
Molecular pathogenesis of long QT syndrome type 1
por: Wu, Jie, et al.
Publicado: (2016)